<DOC>
	<DOCNO>NCT01657201</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic property safety SYP-1018 ( Voriconazole-loaded PNP ) Voriconazole ( Vfend ) .</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetic Properties SYP-1018 ( Voriconazole-loaded PNP ) Voriconazole ( Vfend )</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Healthy adult 2045 year age Weight ≥ 60kg ≤ 90kg BMI ≥ 19 &lt; 27 ( BMI ( kg/m2 ) = weight ( kg ) / { height ( ) } 2 Voluntary write informed consent History presence significant renal , neurologic , pulmonary , endocrine , hematology , oncology , urologic , cardiovascular , musculoskeletal psychiatric disease Drug allergies Voriconazole Recent history evidence drug abuse Recent participation ( within 2 month ) clinical study Recent donation blood ( within 2months ) , plasma ( within 1month ) transfusion ( within 1month )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>